Senior insider sale
Chief Financial Officer at ADAPTIMMUNE THERAPEUTICS PLC — senior position signals high conviction
$942.40
16K shares
What this filing means
WOOD GAVIN plans to sell 16K shares of ADAPTIMMUNE THERAPEUTICS PLC valued at approximately $942.40. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/2/2025ACC: 0001104659-25-086007
Officer· Chief Financial Officer
Since Apr 2020
16K
Shares to sell
$942.40
Approx. market value
16K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Open market purchase
Cash
5/20/2022
6.50KOpen market purchase
Cash
12/14/2020
4KOpen market purchase
Cash
6/29/2020
5.50KTotal acquired16K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/20/2022 | Open market purchase Cash | 6.50K | — |
12/14/2020 | Open market purchase Cash | 4K | — |
6/29/2020 | Open market purchase Cash | 5.50K | — |
| Total | 16K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
16K
Market value
$942.40
9/2/2025
Total
Units
16K
Value
$942.40
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/2/2025 | 16K | $942.40 | Nasdaq | Planned |
| Total | 16K | $942.40 | ||